DODimie OgoinaMBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSASlidesetRSVMonkeypox Clinical Forum 2022Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North - D. Ogoina, MBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSAView Slideset
MGMatthew GagnePhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionScientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy | Matthew GagneView Slideset
TRTracy RuckwardtPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionVaccines for Respiratory Syncytial Virus | Tracy RuckwardtView Slideset
NPNorbert PardiPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionDevelopment of Universal Influenza Vaccines Using Nucleoside-Modified mRNA | Norbert PardiView Slideset
MAMM. Anthony MoodyMDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionClinical Update on mRNA Vaccines for Flu | M. Anthony MoodyView Slideset
KBKarine BreckpotPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionRNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors | Karine BreckpotView Slideset
JRSJohn R. SuMD, PhD, MPHSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionSafety Profiles of COVID-19 Vaccines | John R. SuView Slideset
JBJames BrienPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionPolyvalent Vaccines | James BrienView Slideset
EDElie DolginPhDSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionOpening Lecture on mRNA Technology: Historical Perspective | Elie DolginView Slideset
ABAnna BlakneyPhD, PEngSlidesetHIVRSVCOVID-19OncologyLeveraging mRNA Technology Workshop - 1st EditionAdvances in Nucleic Acid Vaccine Technology | Anna BlakneyView Slideset
IKIvy KasiryeMBChB, MMed, MScSlidesetHIVRSVInternational Workshop on HIV & Pediatrics 2023Elimination of New Paediatric Infections: Where We Are Now and Considerations (...) - Ivy KasiryeView Slideset
